FoRx Therapeutics
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- forxtherapeutics.com
About
FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics that exploit DNA Replication Stress (DRS) as a vulnerability in treatment-resistant cancers. The company is developing oral small molecule drugs, including its lead PARG inhibitor FORX-428, targeting oncology indications where conventional therapies have failed. FoRx focuses on translating the biology of replication stress into best-in-class clinical candidates with a differentiated mechanism of action.
Summary
FoRx Therapeutics is a Biotech company, founded in 2020.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company